Bruker Corporation (BRKR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $9.41B
Last updated: Nov 17, 2026 at 4:20 PM ET
Bruker Corporation (BRKR) Statistics
Bruker (BRKR) has a market cap of $9.41B and an enterprise value of $11.00B. Its trailing P/E is 31.5x.
Total Valuation
Enterprise value is 16.94% above the market cap, as debt exceeds cash.
| Market Cap | $9.41B |
|---|---|
| Enterprise Value | $11.00B |
| Latest price (Nov 17, 2026) | $61.36 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Sep 21, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Last Ex-Dividend Date | Sep 21, 2026 |
| Last Payment Date | Oct 7, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 2.7x. Its year-end P/E ranged from 17.8x to 40.1x from 2016 to 2025.
| P/E Ratio | 31.5x |
|---|---|
| Forward P/E | 28.1x |
| P/S Ratio | 2.7x |
| Forward P/S | 2.7x |
| P/FCF Ratio | 38.2x |
| P/OCF Ratio | 27.5x |
| PEG Ratio | 2.4 |
Enterprise Valuation
Counting debt and cash, the company is valued at 69.5x EBITDA and 44.8x free cash flow.
| EV / Sales | 3.1x |
|---|---|
| EV / EBITDA | 69.5x |
| EV / FCF | 44.8x |
Price Statistics
The stock is up 47.93% over 52 weeks and trades 2.99% above its 50-day average.
| Beta (1Y) | 1.71 |
|---|---|
| 52-Week Change | +47.93% |
| 1-Month Change | +10.82% |
| 3-Month Change | +4.71% |
| 6-Month Change | +44.32% |
| 5-Year Change | -28.93% |
| 10-Year Change | +178.53% |
| Total Return (1Y) | +48.41% |
| Total Return (3Y CAGR) | +0.41% |
| Total Return (5Y CAGR) | -5.75% |
| Return vs SPY (1Y) | +32.77% |
| Max Drawdown (1Y) | -39.85% |
| Max Drawdown (3Y) | -68.72% |
| Sharpe Ratio (1Y) | 0.61 |
| Correlation with SPY (1Y) | 0.39 |
| 50-Day Average | $59.58 |
| 200-Day Average | $50.94 |
| 52-Week Range | $32.27 to $68.98 |
| RSI (14 Days) | 52.1 |
| Average Volume (20 Days) | 2.67M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.84x current liabilities.
| Current Ratio | 1.84x |
|---|---|
| Quick Ratio | 0.90x |
| Debt / EBITDA | 10.87x |
| Debt / FCF | 7.00x |
Returns and Efficiency
| Return on Assets (ROA) | -1.99% |
|---|---|
| Return on Capital Employed (ROCE) | -1.52% |
| ROA (5Y Average) | 5.57% |
| ROIC (5Y Average) | 10.98% |
| Asset Turnover | 0.57x |
| Inventory Turnover | 1.65x |
| Receivables Turnover | 6.33x |
| Cash Conversion Cycle | 238 days |
Scores
BRKR has an Altman Z-Score of 2.38, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.38 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $3.51B over the last 12 months is up 2.16% from the 12 months before.
| Revenue | $3.51B |
|---|---|
| Revenue Growth (YoY) | +2.16% |
| Gross Profit | $1.67B |
| Operating Income | -$69.80M |
| Pretax Income | -$70.90M |
| Net Income | -$115.70M |
| EBITDA | $157.60M |
| EBIT | -$70.90M |
| Reported EPS (TTM) | $1.95 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $119.70M |
|---|---|
| Total Debt | $1.71B |
| Net Debt | $1.59B |
| Net Debt Per Share | $10.45 |
| Working Capital | $985.00M |
| Shareholder Equity | $0 |
| Tangible Book Value | -$2.15B |
| Total Assets | $5.83B |
| Total Liabilities | $3.49B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $97.10M of capital spending, operating cash flow left $244.70M of free cash flow.
| Operating Cash Flow | $341.80M |
|---|---|
| Capital Expenditures | $97.10M |
| Free Cash Flow | $244.70M |
| FCF Per Share | $1.61 |
| Depreciation and Amortization | $228.50M |
| Dividends Paid | $73.40M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -1.99%, against a 5-year average of 11.69%.
| Gross Margin | 47.66% |
|---|---|
| Operating Margin | -1.99% |
| Pretax Margin | -2.02% |
| Net Margin | -3.29% |
| EBITDA Margin | 4.49% |
| EBIT Margin | -2.02% |
| FCF Margin | 6.97% |
| Gross Margin (5Y Average) | 49.52% |
| Operating Margin (5Y Average) | 11.69% |
| Net Margin (5Y Average) | 8.20% |
Growth
Revenue grew 10.74% a year over 3 years, and EPS fell 7.87% a year.
| Revenue Growth (3Y CAGR) | +10.74% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.57% |
| EPS Growth (3Y CAGR) | -7.87% |
| EPS Growth (5Y CAGR) | +6.27% |
| FCF Growth (3Y CAGR) | -33.19% |
| FCF Growth (5Y CAGR) | -28.70% |
| Operating Income Growth (3Y CAGR) | -45.98% |
Dividends and Yields
BRKR pays out 8.92% of earnings as dividends.
| Dividend Per Share (Annual) | $0.20 |
|---|---|
| Dividend Yield | 0.33% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | 0.00% |
| Dividend Growth (5Y CAGR) | +4.56% |
| Payout Ratio | 8.92% |
| FCF Payout Ratio | 12.06% |
| Earnings Yield | 3.17% |
| FCF Yield | 2.62% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.27% |
Peer Position
Against 9 similar companies, BRKR has the 3rd highest P/E.
P/E RatioPeer median 23.6x
P/S RatioPeer median 3.5x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.55%
Dividend YieldPeer median 0.00%
| P/E Ratio | 31.5x vs 23.6x median |
|---|---|
| P/S Ratio | 2.7x vs 3.5x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +2.16% vs +7.55% median |
| Dividend Yield | 0.33% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 3.61% and EPS growth at 15.18% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +3.61% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +15.18% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About BRKR
What is BRKR's market cap?
Bruker has a market cap of $9.41B. Its enterprise value, which adds debt and subtracts cash, is $11.00B.
What is BRKR's P/E ratio?
Bruker has a trailing P/E ratio of 31.5x and a forward P/E of 28.1x.
How many shares of BRKR are outstanding?
Bruker has 152.50M shares outstanding. The count is up 0.46% from a year earlier.
Does BRKR pay a dividend?
Yes. Bruker pays $0.20 a share a year, a dividend yield of 0.33%.
How much debt does BRKR have?
Bruker has $1.71B of total debt and $119.70M of cash and equivalents, a net debt position of $1.59B.
BRKR pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts